Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Reopening of Gaza's Rafah crossing expected Monday
Winter storm death toll in United States reaches 90
Pakistan says 145 militants killed after attacks in Balochistan
Israeli strikes kill 26 in Gaza, health officials say
US government starts likely brief shutdown as House fails to approve deal
Thousands demonstrate in Minnesota and across US to protest ICE
France tightens infant milk rules after recalls
Modi ally proposes social media ban for India's teens as global debate grows
